Abstract
Purpose
Percentage mammographic density (PMD) is a major risk factor for breast cancer (BC). It is strongly associated with body mass index (BMI) and age, which are themselves risk factors for breast cancer. This analysis investigated the association between the number of full-term pregnancies and PMD in different subgroups relative to age and BMI.
Methods
Patients were identified in the breast cancer database of the University Breast Center for Franconia. A total of 2410 patients were identified, for whom information on parity, age, and BMI, and a mammogram from the time of first diagnosis were available for assessing PMD. Linear regression analyses were conducted to investigate the influence on PMD of the number of full-term pregnancies (FTPs), age, BMI, and interaction terms between them.
Results
As in previous studies, age, number of FTPs, and BMI were found to be associated with PMD in the expected direction. However, including the respective interaction terms improved the prediction of PMD even further. Specifically, the association between PMD and the number of FTPs differed in young patients under the age of 45 (mean decrease of 0.37 PMD units per pregnancy) from the association in older age groups (mean decrease between 2.29 and 2.39 PMD units). BMI did not alter the association between PMD and the number of FTPs.
Conclusions
The effect of pregnancies on mammographic density does not appear to become apparent before the age of menopause. The mechanism that drives the effect of pregnancies on mammographic density appears to be counter-regulated by other influences on mammographic density in younger patients.
Similar content being viewed by others
References
Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Haberle L, Loehberg CR, Jud SM, Heusinger K, Rubner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW (2011) Breast cancer risk—genes, environment and clinics. Geburtsh Frauenheilk 71:1056–1066. doi:10.1055/s-0031-1280437
Rauh C, Hack CC, Haberle L, Hein A, Engel A, Schrauder MG, Fasching PA, Jud SM, Ekici AB, Loehberg CR, Meier-Meitinger M, Ozan S, Schulz-Wendtland R, Uder M, Hartmann A, Wachter DL, Beckmann MW, Heusinger K (2012) Percent mammographic density and dense area as risk factors for breast cancer. Geburtshilfe Frauenheilkd 72:727–733. doi:10.1055/s-0032-1315129
Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14:343–349. doi:10.1158/1055-9965.EPI-04-0490
Heusinger K, Loehberg CR, Haeberle L, Jud SM, Klingsiek P, Hein A, Bayer CM, Rauh C, Uder M, Cavallaro A, May MS, Adamietz B, Schulz-Wendtland R, Wittenberg T, Wagner F, Beckmann MW, Fasching PA (2011) Mammographic density as a risk factor for breast cancer in a German case-control study. Eur J Cancer Prev 20:1–8. doi:10.1097/CEJ.0b013e328341e2ce
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227–236. doi:10.1056/NEJMoa062790
McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169. doi:10.1158/1055-9965.EPI-06-0034
Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Haberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rubner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW (2013) Breast cancer risk—from genetics to molecular understanding of pathogenesis. Geburtshilfe Frauenheilkd 73:1228–1235. doi:10.1055/s-0033-1360178
Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894. doi:10.1056/NEJMoa013390
Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G (2005) Breast cancer. Lancet 365:1727–1741. doi:10.1016/S0140-6736(05)66546-4
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770
Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808. doi:10.1016/S1470-2045(05)70390-9
Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14:243–250. doi:10.1097/01.gme.0000235362.72899.7b
Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78:1233–1238
Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11:653–662
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37
van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25:1323–1328. doi:10.1200/JCO.2005.04.7332
Boyd NF, Melnichouk O, Martin LJ, Hislop G, Chiarelli AM, Yaffe MJ, Minkin S (2011) Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol 29:2985–2992. doi:10.1200/JCO.2010.33.7964
Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048–1053
Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744–752. doi:10.1093/jnci/djr079
Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621–628
Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P (2013) Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31:2249–2256. doi:10.1200/JCO.2012.44.5015
van Gils CH, Hendriks JHCL, Otten JDM, Holland R, Verbeek ALM (2000) Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev 9:105–111. doi:10.1097/00008469-200004000-00006
Britt K, Ashworth A, Smalley M (2007) Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14:907–933. doi:10.1677/ERC-07-0137
Morris GJ (2009) Breastfeeding, parity, and reduction of breast cancer risk. Breast J 15:562–563. doi:10.1111/j.1524-4741.2009.00787.x
Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9. doi:10.1056/NEJM199407073310102
Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47
Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1983) Age at any birth and breast cancer risk. Int J Cancer 31:701–704
Nguyen TL, Schmidt DF, Makalic E, Dite GS, Stone J, Apicella C, Bui M, Macinnis RJ, Odefrey F, Cawson JN, Treloar SA, Southey MC, Giles GG, Hopper JL (2013) Explaining variance in the cumulus mammographic measures that predict breast cancer risk: a twins and sisters study. Cancer Epidemiol Biomarkers Prev 22:2395–2403. doi:10.1158/1055-9965.EPI-13-0481
Loehberg CR, Heusinger K, Jud SM, Haeberle L, Hein A, Rauh C, Bani MR, Lux MP, Schrauder MG, Bayer CM, Helbig C, Grolik R, Adamietz B, Schulz-Wendtland R, Beckmann MW, Fasching PA (2010) Assessment of mammographic density before and after first full-term pregnancy. Eur J Cancer Prev 19:405–412. doi:10.1097/CEJ.0b013e32833ca1f4
Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM (2012) Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer 106:996–1003. doi:10.1038/bjc.2012.1
Beckmann MW, Brucker C, Hanf V, Rauh C, Bani MR, Knob S, Petsch S, Schick S, Fasching PA, Hartmann A, Lux MP, Haberle L (2011) Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie 34:362–367. doi:10.1159/000329601
Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV (1998) The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43–47
Heusinger K, Jud SM, Haberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL (2012) Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 135:885–892. doi:10.1007/s10549-012-2221-3
Heusinger K, Jud SM, Haberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA (2012) Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer 131:2643–2649. doi:10.1002/ijc.27515
Yaghjyan L, Colditz GA, Rosner B, Bertrand KA, Tamimi RM (2016) Reproductive factors related to childbearing and mammographic breast density. Breast Cancer Res Treat 158:351–359. doi:10.1007/s10549-016-3884-y
Butler LM, Gold EB, Greendale GA, Crandall CJ, Modugno F, Oestreicher N, Quesenberry CP Jr, Habel LA (2008) Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN). Breast Cancer Res Treat 112:165–174. doi:10.1007/s10549-007-9840-0
El-Bastawissi AY, Aiello EJ, Buist DS, Taplin SH (2005) Previous pregnancy outcome and breast density (United States). Cancer Causes Control 16:407–417. doi:10.1007/s10552-004-5027-8
Lope V, Perez-Gomez B, Sanchez-Contador C, Santamarina MC, Moreo P, Vidal C, Laso MS, Ederra M, Pedraz-Pingarron C, Gonzalez-Roman I, Garcia-Lopez M, Salas-Trejo D, Peris M, Moreno MP, Vazquez-Carrete JA, Collado F, Aragones N, Pollan M, Spain DDM (2012) Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain). Breast Cancer Res Treat 132:1137–1146. doi:10.1007/s10549-011-1936-x
Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA (2006) Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 17:1281–1290. doi:10.1007/s10552-006-0071-1
Modugno F, Ngo DL, Allen GO, Kuller LH, Ness RB, Vogel VG, Costantino JP, Cauley JA (2006) Breast cancer risk factors and mammographic breast density in women over age 70. Breast Cancer Res Treat 97:157–166. doi:10.1007/s10549-005-9105-8
Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA, Hurlbert MS, Benz CC (2014) First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control 25:859–868. doi:10.1007/s10552-014-0386-2
Mockus M, Prebil L, Ereman R, Dollbaum C, Powell M, Yau C, Benz CC (2015) First pregnancy characteristics, postmenopausal breast density, and salivary sex hormone levels in a population at high risk for breast cancer. BBA Clin 3:189–195. doi:10.1016/j.bbacli.2015.02.003
Woolcott CG, Koga K, Conroy SM, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G (2012) Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat 132:1163–1171. doi:10.1007/s10549-011-1929-9
Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, Lopez-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schuz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V (2017) Mammographic density and ageing: a collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS Med 14:e1002335. doi:10.1371/journal.pmed.1002335
McCormack VA, Perry NM, Vinnicombe SJ, Dos Santos Silva I (2010) Changes and tracking of mammographic density in relation to Pike’s model of breast tissue aging: a UK longitudinal study. Int J Cancer 127:452–461. doi:10.1002/ijc.25053
Ginsburg OM, Martin LJ, Boyd NF (2008) Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 99:1369–1374. doi:10.1038/sj.bjc.6604635
Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2006) Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 12:186–193. doi:10.1258/136218006779160436
Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, Colditz GA, Hunter DJ (1999) Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 8:873–879
Meier-Abt F, Bentires-Alj M (2014) How pregnancy at early age protects against breast cancer. Trends Mol Med 20:143–153. doi:10.1016/j.molmed.2013.11.002
Meier-Abt F, Bentires-Alj M, Rochlitz C (2015) Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection. Cancer Res 75:803–807. doi:10.1158/0008-5472.CAN-14-2717
Isfoss BL, Holmqvist B, Jernstrom H, Alm P, Olsson H (2013) Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules. BMC Clin Pathol 13:28. doi:10.1186/1472-6890-13-28
Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88. doi:10.1038/nature04372
Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439:993–997. doi:10.1038/nature04496
Dontu G (2008) Breast cancer stem cell markers—the rocky road to clinical applications. Breast Cancer Res 10:110. doi:10.1186/bcr2130
Acknowledgements
KH was in part funded by the ELAN (“Erlangener Leistungsbezogene Anschubfinanzierung und Nachwuchsförderung”) funding program at Erlangen University Hospital.
Author information
Authors and Affiliations
Contributions
CCH, PAF, and SMJ contributed to the conception of the current analysis, and all of the authors were involved in the design and acquisition of data for the study. WA performed the statistical analysis. LH performed data management. PAF, SMJ, and LH contributed to the analysis and interpretation of the data. CCH, PAF, MWB, and UGP drafted the manuscript. All the authors revised the final draft critically for important content. All of the authors have given final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of interest
PAF has received honoraria from Amgen, Celgene, Roche, Pfizer, Genomic Health, Novartis, and Teva. PG has received honoraria from Novartis. PAF has carried out research for Novartis and Amgen. All the other authors declare that they do not have any conflicts of interest.
Rights and permissions
About this article
Cite this article
Hack, C.C., Emons, J., Jud, S.M. et al. Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis. Breast Cancer Res Treat 166, 701–708 (2017). https://doi.org/10.1007/s10549-017-4446-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-017-4446-7